Example of Journal of Investigative Medicine High Impact Case Reports format
Recent searches

Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format Example of Journal of Investigative Medicine High Impact Case Reports format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access e-ISSN: 23247096

Journal of Investigative Medicine High Impact Case Reports — Template for authors

Publisher: SAGE
Categories Rank Trend in last 3 yrs
Safety Research #54 of 88 down down by None rank
Safety, Risk, Reliability and Quality #114 of 165 down down by None rank
Epidemiology #81 of 99 down down by None rank
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 463 Published Papers | 463 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 29/06/2020
Insights & related journals
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Journal Performance & Insights

  • CiteRatio
  • SJR
  • SNIP

CiteRatio is a measure of average citations received per peer-reviewed paper published in the journal.

1.0

9% from 2019

CiteRatio for Journal of Investigative Medicine High Impact Case Reports from 2016 - 2020
Year Value
2020 1.0
2019 1.1
2018 3.0
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 9% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR) measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

0.247

6% from 2019

SJR for Journal of Investigative Medicine High Impact Case Reports from 2018 - 2020
Year Value
2020 0.247
2019 0.262
2018 0.531
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 6% in last years.
  • This journal’s SJR is in the top 10 percentile category.

Source Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal's category.

0.552

7% from 2019

SNIP for Journal of Investigative Medicine High Impact Case Reports from 2018 - 2020
Year Value
2020 0.552
2019 0.592
2018 0.462
graph view Graph view
table view Table view

insights Insights

  • SNIP of this journal has decreased by 7% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Related Journals

open access Open Access ISSN: 1057610X
recommended Recommended

Taylor and Francis

CiteRatio: 4.0 | SJR: 0.545 | SNIP: 1.328
open access Open Access ISSN: 15477355

De Gruyter

CiteRatio: 3.5 | SJR: 0.304 | SNIP: 0.667
open access Open Access ISSN: 19369751 e-ISSN: 1936976X
recommended Recommended

Springer

CiteRatio: 5.4 | SJR: 0.684 | SNIP: 0.943
open access Open Access ISSN: 22119124
recommended Recommended

Elsevier

CiteRatio: 10.3 | SJR: 2.35 | SNIP: 3.458

Journal of Investigative Medicine High Impact Case Reports

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

SAGE

Journal of Investigative Medicine High Impact Case Reports

Approved by publishing and review experts on SciSpace, this template is built as per for Journal of Investigative Medicine High Impact Case Reports formatting guidelines as mentioned in SAGE author instructions. The current version was created on 29 Jun 2020 and has been used by 816 authors to write and format their manuscripts to this journal.

Pathology

i
Last updated on
29 Jun 2020
i
ISSN
2324-7096
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SageV
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M and Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 1982; 25(7): 4515–4532. URL 10.1103/PhysRevB.25.4515.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1177/2324709614526702
Intravascular Large B-Cell Lymphoma: A Difficult Diagnostic Challenge.
Maria S. Khan1, Mark McCubbin2, Sucha Nand2

Abstract:

Case Presentation. A 69-year-old Hispanic male, with a past history of diabetes and coronary disease, was admitted for fever, diarrhea, and confusion of 4 weeks duration. Physical examination showed a disoriented patient with multiple ecchymoses, possible ascites, and bilateral scrotal swelling. Hemoglobin was 6.7, prothrombi... Case Presentation. A 69-year-old Hispanic male, with a past history of diabetes and coronary disease, was admitted for fever, diarrhea, and confusion of 4 weeks duration. Physical examination showed a disoriented patient with multiple ecchymoses, possible ascites, and bilateral scrotal swelling. Hemoglobin was 6.7, prothrombin time (PT) 21.4 seconds with international normalized ratio 2.1, partial thromboplastin time (PTT) 55.6 seconds, fibrin split 10 µg/L, and lactate dehydrogenase (LDH) 1231 IU/L. Except for a positive DNA test for Epstein-Barr virus (EBV) infection, extensive diagnostic workup for infections, malignancy, or a neurological cause was negative. Mixing studies revealed a nonspecific inhibitor of PT and PTT but Factor VIII levels were normal. The patient was empirically treated with antibiotics but developed hypotension and died on day 27 of admission. At autopsy, patient was found to have intravascular diffuse large B-cell lymphoma involving skin, testes, lung, and muscles. The malignant cells were positive for CD20, CD791, Mum-1, and Pax-5 and negative for CD3, CD5, CD10, CD30, and Bcl-6. The malignant cells were 100% positive for Ki-67. Discussion. Intravascular large cell B-cell lymphoma (IVLBCL) is rare form of diffuse large B-cell lymphoma and tends to proliferate within small blood vessels, particularly capillaries and postcapillary venules. The cause of its affinity for vascular bed remains unknown. In many reports, IVLBCL was associated with HIV, HHV8, and EBV infections. The fact that our case showed evidence of EBV infection lends support to the association of this diagnosis to viral illness. The available literature on this subject is scant, and in many cases, the diagnosis was made only at autopsy. The typical presentation of this disorder is with B symptoms, progressive neurologic deficits, and skin findings. Bone marrow, spleen, and liver are involved in a minority of patients. Nearly all patients have elevated LDH, and about 65% are anemic. About 20% have hepatic and renal dysfunction. The treatment consists of systemic chemotherapy with cyclophosphamide, doxorubicin, vincristine, prednisone plus rituximab (CHOP-R) and central nervous system prophylaxis. Retrospective data suggests that, with treatment, 51% to 82% of the patients achieve a complete remission and 27% to 56% are alive at 2-year follow-up. Conclusion. IVLBCL is a difficult diagnosis to make as the disease remains confined to the vascular lumen. It may be associated with certain viral illnesses, and this association needs to be explored further. It is important to consider this diagnosis in the appropriate settings because patients may achieve durable remissions with therapy. read more read less

Topics:

Intravascular large B-cell lymphoma (61%)61% related to the paper, B symptoms (55%)55% related to the paper, Rituximab (52%)52% related to the paper, Large cell (52%)52% related to the paper, Lymphoma (50%)50% related to the paper
View PDF
105 Citations
open accessOpen access Journal Article DOI: 10.1177/2324709613480346
Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management
Sumandeep Dhesi1, Michael P. Chu1, Gregg Blevins1, Ian Paterson1, Loree Larratt1, Gavin Y. Oudit1, Daniel Kim1

Abstract:

Cyclophosphamide is increasingly used to treat various types of cancers and autoimmune conditions. Higher doses of this drug may produce significant cardiac toxicity, including fatal hemorrhagic myocarditis. In this review, we present a case of cyclophosphamide-induced cardiomyopathy requiring mechanical circulatory support. ... Cyclophosphamide is increasingly used to treat various types of cancers and autoimmune conditions. Higher doses of this drug may produce significant cardiac toxicity, including fatal hemorrhagic myocarditis. In this review, we present a case of cyclophosphamide-induced cardiomyopathy requiring mechanical circulatory support. We also describe the pathophysiology, clinical manifestations, and risk factors for this important clinical entity and propose early detection and management strategies. read more read less

Topics:

Cardiomyopathy (56%)56% related to the paper, Myocarditis (51%)51% related to the paper
View PDF
57 Citations
open accessOpen access Journal Article DOI: 10.1177/2324709616674316
Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases.
Sneha Phadke1, Ramez Ghabour1, Brian L. Swick1, Andrea Swenson1, Mohammed M. Milhem1, Yousef Zakharia1

Abstract:

Historically, metastatic melanoma was uniformly and rapidly lethal, and treatment options were limited. In recent years, however, checkpoint inhibitors have emerged as an accepted standard treatment for patients with advanced melanoma. In clinical trials, these agents have been largely well tolerated and have the potential to... Historically, metastatic melanoma was uniformly and rapidly lethal, and treatment options were limited. In recent years, however, checkpoint inhibitors have emerged as an accepted standard treatment for patients with advanced melanoma. In clinical trials, these agents have been largely well tolerated and have the potential to result in durable responses. Importantly though, one must recognize the unique side effect profile of these therapies, which can trigger or exacerbate underlying autoimmune disease. Whether this autoimmune activation is associated with a clinical response to therapy has been debated, and while not definitive, there is evidence in the literature of a possible association. The 2 cases presented describe this autoimmune phenomenon, along with a review of the existing literature on the relationship between response to immunotherapy and autoimmune side effects. read more read less

Topics:

Autoimmune disease (56%)56% related to the paper, Pembrolizumab (55%)55% related to the paper
View PDF
45 Citations
open accessOpen access Journal Article DOI: 10.1177/2324709614556129
Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice

Abstract:

Three young women who developed premature ovarian insufficiency following quadrivalent human papillomavirus (HPV) vaccination presented to a general practitioner in rural New South Wales, Australia The unrelated girls were aged 16, 16, and 18 years at diagnosis Each had received HPV vaccinations prior to the onset of ovarian ... Three young women who developed premature ovarian insufficiency following quadrivalent human papillomavirus (HPV) vaccination presented to a general practitioner in rural New South Wales, Australia The unrelated girls were aged 16, 16, and 18 years at diagnosis Each had received HPV vaccinations prior to the onset of ovarian decline Vaccinations had been administered in different regions of the state of New South Wales and the 3 girls lived in different towns in that state Each had been prescribed the oral contraceptive pill to treat menstrual cycle abnormalities prior to investigation and diagnosis Vaccine research does not present an ovary histology report of tested rats but does present a testicular histology report Enduring ovarian capacity and duration of function following vaccination is unresearched in preclinical studies, clinical and postlicensure studies Postmarketing surveillance does not accurately represent diagnoses in adverse event notifications and can neither represent unnotified cases nor compare incident statistics with vaccine course administration rates The potential significance of a case series of adolescents with idiopathic premature ovarian insufficiency following HPV vaccination presenting to a general practice warrants further research Preservation of reproductive health is a primary concern in the recipient target group Since this group includes all prepubertal and pubertal young women, demonstration of ongoing, uncompromised safety for the ovary is urgently required This matter needs to be resolved for the purposes of population health and public vaccine confidence read more read less

Topics:

Premature ovarian insufficiency (58%)58% related to the paper, Premature ovarian failure (54%)54% related to the paper, Vaccination (53%)53% related to the paper, Postmarketing surveillance (51%)51% related to the paper
View PDF
45 Citations
open accessOpen access Journal Article DOI: 10.1177/2324709620934674
A Case Series of Patients Coinfected With Influenza and COVID-19.

Abstract:

Coronavirus disease 2019, also called COVID-19, is a global pandemic resulting in significant morbidity and mortality worldwide. In the United States, influenza infection occurs mainly during winter and several factors influence the burden of the disease, including circulating virus characteristics, vaccine effectiveness that... Coronavirus disease 2019, also called COVID-19, is a global pandemic resulting in significant morbidity and mortality worldwide. In the United States, influenza infection occurs mainly during winter and several factors influence the burden of the disease, including circulating virus characteristics, vaccine effectiveness that season, and the duration of the season. We present a case series of 3 patients with coinfection of COVID-19 and influenza, with 2 of them treated successfully and discharged home. We reviewed the literature of patients coinfected with both viruses and discussed the characteristics, as well as treatment options. read more read less

Topics:

Coinfection (54%)54% related to the paper, Pandemic (53%)53% related to the paper
View PDF
32 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Journal of Investigative Medicine High Impact Case Reports.

It automatically formats your research paper to SAGE formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Journal of Investigative Medicine High Impact Case Reports format uses SageV citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

Absolutely not! With our tool, you can freely write without having to focus on LaTeX. You can write your entire paper as per the Journal of Investigative Medicine High Impact Case Reports guidelines and autoformat it.

Yes. The template is fully compliant as per the guidelines of this journal. Our experts at SciSpace ensure that. Also, if there's any update in the journal format guidelines, we take care of it and include that in our algorithm.

Sure. We support all the top citation styles like APA style, MLA style, Vancouver style, Harvard style, Chicago style, etc. For example, in case of this journal, when you write your paper and hit autoformat, it will automatically update your article as per the Journal of Investigative Medicine High Impact Case Reports citation style.

You can avail our Free Trial for 7 days. I'm sure you'll find our features very helpful. Plus, it's quite inexpensive.

Yup. You can choose the right template, copy-paste the contents from the word doc and click on auto-format. You'll have a publish-ready paper that you can download at the end.

A matter of seconds. Besides that, our intuitive editor saves a load of your time in writing and formating your manuscript.

One little Google search can get you the Word template for any journal. However, why do you need a Word template when you can write your entire manuscript on SciSpace, autoformat it as per Journal of Investigative Medicine High Impact Case Reports's guidelines and download the same in Word, PDF and LaTeX formats? Try us out!.

Absolutely! You can do it using our intuitive editor. It's very easy. If you need help, you can always contact our support team.

SciSpace is an online tool for now. We'll soon release a desktop version. You can also request (or upvote) any feature that you think might be helpful for you and the research community in the feature request section once you sign-up with us.

Sure. You can request any template and we'll have it up and running within a matter of 3 working days. You can find the request box in the Journal Gallery on the right sidebar under the heading, "Couldn't find the format you were looking for?".

After you have written and autoformatted your paper, you can download it in multiple formats, viz., PDF, Docx and LaTeX.

To be honest, the answer is NO. The impact factor is one of the many elements that determine the quality of a journal. Few of those factors the review board, rejection rates, frequency of inclusion in indexes, Eigenfactor, etc. You must assess all the factors and then take the final call.

SHERPA/RoMEO Database

We have extracted this data from Sherpa Romeo to help our researchers understand the access level of this journal. The following table indicates the level of access a journal has as per Sherpa Romeo Archiving Policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

The 5 most common citation types in order of usage are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

Our journal submission experts are skilled in submitting papers to various international journals.

After uploading your paper on SciSpace, you would see a button to request a journal submission service for Journal of Investigative Medicine High Impact Case Reports.

Each submission service is completed within 4 - 5 working days.

Yes. SciSpace provides this functionality.

After signing up, you would need to import your existing references from Word or .bib file.

SciSpace would allow download of your references in Journal of Investigative Medicine High Impact Case Reports Endnote style, according to sage guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Journal of Investigative Medicine High Impact Case Reports formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template